hTERT-promoter-based tumor-specific expression of MCP-1 effectively sensitizes cervical cancer cells to a low dose of cisplatin.

Source:http://linkedlifedata.com/resource/pubmed/id/14681721

Download in:

View as

General Info

PMID
14681721